SubsidieMeesters logoSubsidieMeesters
ProjectenRegelingenAnalyses

Formate-dependent Regulation of Cancer Metastasis

This project aims to elucidate the role of formate overflow in cancer metastasis and develop targeted therapies by investigating mitochondrial one-carbon metabolism and its signaling mechanisms.

Subsidie
€ 2.000.000
2024

Projectdetails

Introduction

Mechanisms underlying cancer metastasis are poorly understood and context dependent. An essential feature of disseminating cancer cells is metabolic plasticity, which allows cellular adaptation to changing environmental conditions along the metastatic cascade.

Discovery of Formate Overflow

I discovered in 2016 the phenomenon of formate overflow, an alternative pathway for serine catabolism via folate-mediated one-carbon (1C) cycle. Instead of using formate for nucleotide synthesis (to support proliferation), formate overflow is characterized by formate excretion from cancer cells.

Impact on Cancer Metastasis

Furthermore, I have convincingly demonstrated that mitochondrial 1C metabolism and increased extracellular formate concentrations promote cancer metastasis in a growth-independent manner. However, it remains unknown which intermediates of 1C metabolism contribute to this phenotype, how formate controls metastasis, and how it can be targeted therapeutically.

Research Objectives

To cross the current edge of knowledge, I will:

  1. Take advantage of genetic and newly developed analytical methods to dissect how the formate-dependent effects are propagated in cells.
  2. Describe intrinsic mechanisms to explain how the formate signal is relayed to promote metastasis.
  3. Exploit formate overflow for cancer cell killing by directly targeting the formate molecule.

Novel Concept and Tool Development

4M8 will explain a novel concept of how a mitochondrial metabolic signal drives cancer cells towards a pro-metastatic phenotype and how this knowledge can be translated into a signature to analyze the metabolic state in human tumor samples.

Finally, we will develop a novel tool to target formate directly within cancer cells.

Conclusion

In sum, our research will shed light on an unexplored field of cancer metabolism, providing the foundation to develop novel treatment approaches against metastatic cancer, the primary cause of cancer death.

Financiële details & Tijdlijn

Financiële details

Subsidiebedrag€ 2.000.000
Totale projectbegroting€ 2.000.000

Tijdlijn

Startdatum1-5-2024
Einddatum30-4-2029
Subsidiejaar2024

Partners & Locaties

Projectpartners

  • LUXEMBOURG INSTITUTE OF HEALTHpenvoerder

Land(en)

Luxembourg

Inhoudsopgave

European Research Council

Financiering tot €10 miljoen voor baanbrekend frontier-onderzoek via ERC-grants (Starting, Consolidator, Advanced, Synergy, Proof of Concept).

Bekijk regeling

Vergelijkbare projecten binnen European Research Council

ProjectRegelingBedragJaarActie

Targeting the Metabolic Dependencies of Metastatic Tumor Cells

This project aims to identify and target unique amino acid dependencies in metastatic melanoma cells to develop novel therapies that prevent metastasis and improve cancer treatment outcomes.

ERC Starting...€ 1.493.750
2024
Details

​Targeting Palmitic Acid Signaling Machinery to Inhibit Metastatic Cancer

PalmitoMET seeks to discover inhibitors of specific protein lipidation to combat cancer metastasis, aiming to develop first-in-class drugs for preclinical and clinical applications.

ERC Proof of...€ 150.000
2023
Details

Functional characterization of the colorectal cancer metastasis microbiome

The METABAC project aims to investigate the functional roles of bacteria in colorectal cancer metastasis using innovative platforms to uncover their impact on cancer progression and potential therapeutic targets.

ERC Starting...€ 1.499.894
2024
Details

The role of Palmitoylation ERASERs in cancer metastasis

This project aims to uncover the role of palmitoylation erasers in promoting breast cancer metastasis, using multi-omics and in vivo models to develop targeted therapies based on dietary influences.

ERC Starting...€ 1.495.519
2024
Details

Intercellular trading in nucleotide metabolism: an emerging target

This project aims to identify nucleotide sources and metabolic interactions in cancer and stromal cells using single-cell multi-omics to develop targeted therapies against nucleotide-dependent tumors.

ERC Starting...€ 1.450.000
2022
Details
ERC Starting...

Targeting the Metabolic Dependencies of Metastatic Tumor Cells

This project aims to identify and target unique amino acid dependencies in metastatic melanoma cells to develop novel therapies that prevent metastasis and improve cancer treatment outcomes.

ERC Starting Grant
€ 1.493.750
2024
Details
ERC Proof of...

​Targeting Palmitic Acid Signaling Machinery to Inhibit Metastatic Cancer

PalmitoMET seeks to discover inhibitors of specific protein lipidation to combat cancer metastasis, aiming to develop first-in-class drugs for preclinical and clinical applications.

ERC Proof of Concept
€ 150.000
2023
Details
ERC Starting...

Functional characterization of the colorectal cancer metastasis microbiome

The METABAC project aims to investigate the functional roles of bacteria in colorectal cancer metastasis using innovative platforms to uncover their impact on cancer progression and potential therapeutic targets.

ERC Starting Grant
€ 1.499.894
2024
Details
ERC Starting...

The role of Palmitoylation ERASERs in cancer metastasis

This project aims to uncover the role of palmitoylation erasers in promoting breast cancer metastasis, using multi-omics and in vivo models to develop targeted therapies based on dietary influences.

ERC Starting Grant
€ 1.495.519
2024
Details
ERC Starting...

Intercellular trading in nucleotide metabolism: an emerging target

This project aims to identify nucleotide sources and metabolic interactions in cancer and stromal cells using single-cell multi-omics to develop targeted therapies against nucleotide-dependent tumors.

ERC Starting Grant
€ 1.450.000
2022
Details

Vergelijkbare projecten uit andere regelingen

ProjectRegelingBedragJaarActie

3D spheroids derived from single cells for discovering stochastic patterns behind metastasis

3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.

EIC Pathfinder€ 2.591.050
2023
Details

A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy

The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.

EIC Pathfinder€ 2.982.792
2022
Details
EIC Pathfinder

3D spheroids derived from single cells for discovering stochastic patterns behind metastasis

3DSecret aims to revolutionize cancer treatment by analyzing single circulating tumor cells using advanced technologies to uncover stochastic patterns driving metastasis and improve diagnosis and prognosis.

EIC Pathfinder
€ 2.591.050
2023
Details
EIC Pathfinder

A multiplexed biomimetic imaging platform for assessing single cell plasticity (Plastomics) and scoring of tumour malignancy

The PLAST_CELL project aims to develop a microfluidics-based imaging platform to quantify cancer cell plasticity, enhancing diagnosis and treatment of metastasis and therapy resistance.

EIC Pathfinder
€ 2.982.792
2022
Details

SubsidieMeesters logoSubsidieMeesters

Vind en verken subsidieprojecten in Nederland en Europa.

Links

  • Projecten
  • Regelingen
  • Analyses

Suggesties

Heb je ideeën voor nieuwe features of verbeteringen?

Deel je suggestie
© 2025 SubsidieMeesters. Alle rechten voorbehouden.